These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 23371914)

  • 21. Increased Brain Lactate During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Drug-Naive Bipolar Disorder: A 3-T 1H-MRS Study.
    Machado-Vieira R; Zanetti MV; Otaduy MC; De Sousa RT; Soeiro-de-Souza MG; Costa AC; Carvalho AF; Leite CC; Busatto GF; Zarate CA; Gattaz WF
    J Clin Psychopharmacol; 2017 Feb; 37(1):40-45. PubMed ID: 27902528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular actions and clinical pharmacogenetics of lithium therapy.
    Can A; Schulze TG; Gould TD
    Pharmacol Biochem Behav; 2014 Aug; 123():3-16. PubMed ID: 24534415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
    Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
    Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
    Won E; Kim YK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic lithium salt treatment reduces CRE/CREB-directed gene transcription and reverses its upregulation by chronic psychosocial stress in transgenic reporter gene mice.
    Böer U; Cierny I; Krause D; Heinrich A; Lin H; Mayr G; Hiemke C; Knepel W
    Neuropsychopharmacology; 2008 Sep; 33(10):2407-15. PubMed ID: 18046304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the mechanism of action of lithium in the brain: fifty-year update.
    Lenox RH; Hahn CG
    J Clin Psychiatry; 2000; 61 Suppl 9():5-15. PubMed ID: 10826655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lithium specificity in bipolar illness: a classic agent for the classic disorder.
    Gershon S; Chengappa KN; Malhi GS
    Bipolar Disord; 2009 Jun; 11 Suppl 2():34-44. PubMed ID: 19538684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder.
    Hahn CG; Friedman E
    Bipolar Disord; 1999 Dec; 1(2):81-6. PubMed ID: 11252663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular effects of lithium.
    Quiroz JA; Gould TD; Manji HK
    Mol Interv; 2004 Oct; 4(5):259-72. PubMed ID: 15471909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium treatment - the state of the art for 2020.
    Rybakowski J
    Psychiatr Pol; 2020 Dec; 54(6):1047-1066. PubMed ID: 33740796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with lithium efficacy in bipolar disorder.
    Rybakowski JK
    Harv Rev Psychiatry; 2014; 22(6):353-7. PubMed ID: 25377609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mood stabilizers--past, present and future].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Mar; 10(1):31-42. PubMed ID: 18771018
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lithium and cognition in those with bipolar disorder.
    Paterson A; Parker G
    Int Clin Psychopharmacol; 2017 Mar; 32(2):57-62. PubMed ID: 27741027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders.
    Bauer M; Alda M; Priller J; Young LT;
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S250-4. PubMed ID: 14677087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
    Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
    J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mood-stabilizing drugs on dendritic outgrowth and synaptic protein levels in primary hippocampal neurons.
    Park SW; Lee JG; Seo MK; Cho HY; Lee CH; Lee JH; Lee BJ; Baek JH; Seol W; Kim YH
    Bipolar Disord; 2015 May; 17(3):278-90. PubMed ID: 25307211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium and Therapeutic Targeting of GSK-3.
    Snitow ME; Bhansali RS; Klein PS
    Cells; 2021 Jan; 10(2):. PubMed ID: 33525562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lithium: A classic drug-Frequently discussed, but, sadly, seldom prescribed!
    Zivanovic O
    Aust N Z J Psychiatry; 2017 Sep; 51(9):886-896. PubMed ID: 28403623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new avenue for lithium: intervention in traumatic brain injury.
    Leeds PR; Yu F; Wang Z; Chiu CT; Zhang Y; Leng Y; Linares GR; Chuang DM
    ACS Chem Neurosci; 2014 Jun; 5(6):422-33. PubMed ID: 24697257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A longitudinal study of fronto-limbic brain structures in patients with bipolar I disorder during lithium treatment.
    Selek S; Nicoletti M; Zunta-Soares GB; Hatch JP; Nery FG; Matsuo K; Sanches M; Soares JC
    J Affect Disord; 2013 Sep; 150(2):629-33. PubMed ID: 23764385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.